|
CN104661664B
(zh)
|
2012-07-13 |
2020-07-03 |
波涛生命科学有限公司 |
手性控制
|
|
CN113278617A
(zh)
|
2014-01-16 |
2021-08-20 |
波涛生命科学有限公司 |
手性设计
|
|
MA43072A
(fr)
|
2015-07-22 |
2018-05-30 |
Wave Life Sciences Ltd |
Compositions d'oligonucléotides et procédés associés
|
|
MA45188A
(fr)
|
2016-06-03 |
2019-04-10 |
Wave Life Sciences Ltd |
Oligonucléotides, compositions et méthodes associées
|
|
AU2017281497B2
(en)
|
2016-06-22 |
2023-04-06 |
Proqr Therapeutics Ii B.V. |
Single-stranded RNA-editing oligonucleotides
|
|
PL3507366T3
(pl)
|
2016-09-01 |
2021-05-04 |
Proqr Therapeutics Ii B.V. |
Chemicznie modyfikowane jednoniciowe oligonukleotydy edytujące rna
|
|
MA46905A
(fr)
|
2016-11-23 |
2019-10-02 |
Wave Life Sciences Ltd |
Compositions et procédés de synthèse de phosphoramidites et d'oligonucléotides
|
|
EP3630789A4
(en)
|
2017-06-02 |
2021-06-16 |
Wave Life Sciences Ltd. |
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THEIR USE
|
|
CN111050806A
(zh)
|
2017-06-02 |
2020-04-21 |
波涛生命科学有限公司 |
寡核苷酸组合物及其使用方法
|
|
JP7402696B2
(ja)
|
2017-06-21 |
2023-12-21 |
ウェイブ ライフ サイエンシズ リミテッド |
合成のための化合物、組成物、及び方法
|
|
WO2019032607A1
(en)
|
2017-08-08 |
2019-02-14 |
Wave Life Sciences Ltd. |
OLIGONUCLEOTIDE COMPOSITIONS AND RELATED METHODS
|
|
KR20250123934A
(ko)
|
2017-09-18 |
2025-08-18 |
웨이브 라이프 사이언시스 리미티드 |
올리고뉴클레오티드 제조 기술
|
|
US11596646B2
(en)
|
2017-10-12 |
2023-03-07 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
US12391942B2
(en)
|
2018-05-11 |
2025-08-19 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods of use thereof
|
|
GB201808146D0
(en)
|
2018-05-18 |
2018-07-11 |
Proqr Therapeutics Ii Bv |
Stereospecific Linkages in RNA Editing Oligonucleotides
|
|
WO2023152371A1
(en)
|
2022-02-14 |
2023-08-17 |
Proqr Therapeutics Ii B.V. |
Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
|
|
WO2024013361A1
(en)
|
2022-07-15 |
2024-01-18 |
Proqr Therapeutics Ii B.V. |
Oligonucleotides for adar-mediated rna editing and use thereof
|
|
EP4555085A1
(en)
|
2022-07-15 |
2025-05-21 |
ProQR Therapeutics II B.V. |
Chemically modified oligonucleotides for adar-mediated rna editing
|
|
GB202215614D0
(en)
|
2022-10-21 |
2022-12-07 |
Proqr Therapeutics Ii Bv |
Heteroduplex rna editing oligonucleotide complexes
|
|
WO2024110565A1
(en)
|
2022-11-24 |
2024-05-30 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
|
|
GB202218090D0
(en)
|
2022-12-01 |
2023-01-18 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for the treatment of aldehyde dehydrogenase 2 deficiency
|
|
CN120322556A
(zh)
|
2022-12-09 |
2025-07-15 |
ProQR治疗上市公司Ⅱ |
用于治疗心血管疾病的反义寡核苷酸
|
|
GB202300865D0
(en)
|
2023-01-20 |
2023-03-08 |
Proqr Therapeutics Ii Bv |
Delivery of oligonucleotides
|
|
WO2024175550A1
(en)
|
2023-02-20 |
2024-08-29 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of atherosclerotic cardiovascular disease
|
|
WO2024206175A1
(en)
|
2023-03-24 |
2024-10-03 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of neurological disorders
|
|
GB202304363D0
(en)
|
2023-03-24 |
2023-05-10 |
Proqr Therapeutics Ii Bv |
Chemically modified antisense oligonucleotides for use in RNA editing
|
|
KR20250167580A
(ko)
|
2023-03-27 |
2025-12-01 |
프로큐알 테라퓨틱스 Ⅱ 비.브이. |
간 질환 치료용 안티센스 올리고뉴클레오타이드
|
|
WO2024256620A1
(en)
|
2023-06-16 |
2024-12-19 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of neurodegenerative disease
|
|
WO2025051946A1
(en)
|
2023-09-07 |
2025-03-13 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of metabolic disorders
|
|
WO2025070241A1
(ja)
*
|
2023-09-25 |
2025-04-03 |
藤本化学製品株式会社 |
化合物又はその塩、並びにその製造方法
|
|
WO2025072886A1
(en)
*
|
2023-09-28 |
2025-04-03 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
WO2025096809A1
(en)
*
|
2023-10-31 |
2025-05-08 |
Korro Bio, Inc. |
Oligonucleotides comprising phosphoramidate internucleotide linkages
|
|
WO2025104239A1
(en)
|
2023-11-16 |
2025-05-22 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of classic galactosemia
|
|
WO2025132708A1
(en)
|
2023-12-20 |
2025-06-26 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of huntington's disease
|
|
WO2025151895A1
(en)
*
|
2024-01-12 |
2025-07-17 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
GB202404661D0
(en)
|
2024-04-02 |
2024-05-15 |
Proqr Therapeutics Ii Bv |
Antisense oligoncleotides for the treatment of liver disease
|
|
WO2025224230A1
(en)
|
2024-04-25 |
2025-10-30 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of fatty liver disease
|